| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
30,821 |
29,985 |
$761K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
30,560 |
29,747 |
$752K |
| 81513 |
|
8,656 |
8,362 |
$532K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
19,046 |
18,445 |
$448K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
22,719 |
22,428 |
$433K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
7,064 |
5,715 |
$366K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
13,151 |
12,964 |
$326K |
| 87481 |
|
15,383 |
11,466 |
$282K |
| 87653 |
|
9,226 |
8,682 |
$216K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,834 |
1,693 |
$123K |
| 88141 |
|
6,518 |
6,421 |
$110K |
| 88342 |
|
1,498 |
1,191 |
$81K |
| 87511 |
|
3,211 |
3,108 |
$53K |
| 88142 |
|
2,839 |
2,776 |
$41K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
1,543 |
1,434 |
$34K |
| 88312 |
|
231 |
223 |
$20K |
| 87480 |
|
1,567 |
1,507 |
$20K |
| 88341 |
|
178 |
164 |
$16K |
| 88304 |
|
454 |
437 |
$15K |
| 87660 |
|
1,555 |
1,501 |
$15K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
266 |
264 |
$15K |
| 87510 |
|
1,557 |
1,499 |
$14K |
| 87625 |
|
380 |
372 |
$9K |
| 88173 |
|
74 |
69 |
$6K |
| 87529 |
|
111 |
101 |
$4K |
| 87070 |
|
362 |
349 |
$2K |
| 88313 |
|
110 |
56 |
$1K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
43 |
42 |
$718.37 |
| 87186 |
|
53 |
45 |
$187.87 |
| 87075 |
|
42 |
41 |
$183.19 |
| 87205 |
|
77 |
75 |
$182.12 |
| 87077 |
|
14 |
12 |
$30.75 |
| G0476 |
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test |
307 |
221 |
$0.00 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
763 |
664 |
$0.00 |